|
C14ORF143 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.124210E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.538000E-02 |
| Normal-vs-Stage2 |
1.170140E-02 |
| Normal-vs-Stage3 |
8.358600E-01 |
| Normal-vs-Stage4 |
1.100170E-01 |
| Stage1-vs-Stage2 |
2.574400E-01 |
| Stage1-vs-Stage3 |
1.818210E-01 |
| Stage1-vs-Stage4 |
5.960600E-01 |
| Stage2-vs-Stage3 |
6.673700E-02 |
| Stage2-vs-Stage4 |
7.767600E-01 |
| Stage3-vs-Stage4 |
2.973800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.235840E-01 |
| Normal-vs-AfricanAmerican |
7.880300E-02 |
| Normal-vs-Asian |
5.165600E-01 |
| Caucasian-vs-AfricanAmerican |
6.018400E-01 |
| Caucasian-vs-Asian |
1.810820E-01 |
| AfricanAmerican-vs-Asian |
1.404210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.837700E-02 |
| Normal-vs-Female |
9.248400E-01 |
| Male-vs-Female |
4.939400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.108200E-02 |
| Normal-vs-Extreme_Weight |
3.815800E-02 |
| Normal-vs-Obese |
3.192200E-01 |
| Normal-vs-Extreme_Obese |
3.134400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.094400E-01 |
| Normal_Weight-vs-Obese |
2.448600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.116200E-01 |
| Extreme_Weight-vs-Obese |
2.074400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.425400E-01 |
| Obese-vs-Extreme_Obese |
6.803400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.830000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.083800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.060000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.231800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.615000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.410800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.000010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.305030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.302400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.990590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.057700E-02 |
| Normal-VS-Type2 PRCC |
2.556800E-01 |
| Normal-VS-KIRP CIMP |
7.595400E-01 |
| Normal-VS-Unclassified PRCC |
1.775770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.857980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.026500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.398400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.308200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.262400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.770400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.827500E-02 |
| Normal-vs-N1 |
6.555800E-01 |
| Normal-vs-N2 |
8.038300E-02 |
| N0-vs-N1 |
7.299500E-02 |
| N0-vs-N2 |
4.377800E-01 |
| N1-vs-N2 |
1.352160E-01 |
|
|
